Healthcare -
Biotechnology - NASDAQ - US
$ 78.02
1.65 %
$ 5.6 B
Market Cap
-17.67
P/E
NUVL - OPERATING INCOME
Operating Income NUVL - Nuvalent, Inc.
-280 M
LAST VALUE
-80.44%
2 YEAR CAGR
-93.42%
5 YEAR CAGR
0.00%
10 YEAR CAGR